There are 17 autonomous regions in Spain, each can make distinct price/reimbursement decisions for drugs. To drive more consistency, the Spanish Agency for Medicines and Health Products have issued national Therapeutic Positioning Reports (TPRs) for new medicines since 2012. These comparative efficacy and safety reports specify the patient population that will benefit most. This research analyses the number, indications and outcomes of TPRs.
Authors: Richard Macaulay, Raquel Fernandez Dacosta
To find out more about this poster you can register to download it here after the ISPOR event.